Venclyxto 100mg-G (Venetoklaks Tablet) 100mg

Venclyxto 100mg-G (Venetoklaks) is an oral tablet used for chronic lymphocytic leukemia and small lymphocytic lymphoma treatment. This 100mg strength medication supports targeted therapy in blood cancers. Store at room temperature and follow professional guidance for safe use.

Strength

100mg

Pack Size

14s

Storage

Ambient

Manufacturer / TM Owner

Abbvie

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venetoklaks is prescribed to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma, particularly when other therapies are unsuitable. It works by targeting specific proteins in cancer cells to slow disease progression. Patients often ask what is venetoklaks used for, and this medication is designed for targeted cancer therapy in approved indications.

Side Effects

Venetoklaks may cause mild to moderate side effects such as nausea, fatigue, or low blood cell counts. Some users report digestive discomfort or reduced appetite during treatment. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

Keep venetoklaks tablets in their original packaging at room temperature away from moisture and heat. Avoid crushing or splitting tablets unless directed by a medical professional. Always follow storage instructions and consult your pharmacist with any handling questions.

Avoid Interactions

Venetoklaks can interact with certain medications, including strong CYP3A inhibitors or inducers, which may affect its effectiveness. Alcohol and grapefruit products may also interact with venetoklaks. Discuss all current medications with your doctor before starting treatment.

Frequently Asked Questions

Venetoklaks is used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Store venetoklaks 100mg tablets at room temperature in their original packaging.

Do not split or crush venetoklaks tablets unless instructed by a healthcare professional.

Venetoklaks may interact with CYP3A inhibitors, inducers, alcohol, and grapefruit products.

Common side effects include nausea, fatigue, and low blood cell counts.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 28 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.